Hospital.Help

Amsterdam The European Medicines Agency (EMA) is reviewing the safety of drugs that contain the painkiller metamizole (Novaminsulfon). There are fears that the existing measures to reduce the risk of agranulocytosis are not sufficient. Agranulocytosis, a drop in granulocytes to less than 500 cells/l of blood, is a known side effect of metamizole. It can lead to serious infections with fatal…